newsfilter
← Latest News
FDA Approved Drugs·

Approval of Kesimpta, Bla #125326

Approval Date: 04/01/2026; Drug Name: Kesimpta, Bla #125326; Active Ingredients: OFATUMUMAB; Company: Novartis; Submission Status: Approval; Application Number: 125326

Company
NOVARTIS
Keywords
NOVARTIS